PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,000 | -14.9% | 9,875 | +53.4% | 0.00% | – |
| Q2 2023 | $261,000 | -46.5% | 6,439 | -36.1% | 0.00% | – |
| Q1 2023 | $488,000 | -17.6% | 10,081 | -35.0% | 0.00% | – |
| Q4 2022 | $592,000 | +175.3% | 15,518 | +262.7% | 0.00% | – |
| Q3 2022 | $215,000 | -3.2% | 4,279 | -23.0% | 0.00% | – |
| Q2 2022 | $222,000 | -65.9% | 5,558 | -68.1% | 0.00% | – |
| Q1 2022 | $651,000 | -43.6% | 17,442 | -39.9% | 0.00% | – |
| Q4 2021 | $1,155,000 | +14.8% | 29,001 | +7.2% | 0.00% | – |
| Q3 2021 | $1,006,000 | -47.7% | 27,047 | -40.6% | 0.00% | – |
| Q2 2021 | $1,923,000 | +100.1% | 45,502 | +124.4% | 0.00% | – |
| Q1 2021 | $961,000 | +34.0% | 20,281 | +72.8% | 0.00% | – |
| Q4 2020 | $717,000 | +23.0% | 11,738 | -5.9% | 0.00% | – |
| Q3 2020 | $583,000 | -8.5% | 12,475 | -0.8% | 0.00% | – |
| Q2 2020 | $637,000 | +39.4% | 12,571 | +22.7% | 0.00% | – |
| Q1 2020 | $457,000 | -65.6% | 10,245 | -63.0% | 0.00% | – |
| Q4 2019 | $1,328,000 | +49.2% | 27,667 | +5.1% | 0.00% | – |
| Q3 2019 | $890,000 | -31.1% | 26,319 | -8.4% | 0.00% | -100.0% |
| Q2 2019 | $1,292,000 | -5.6% | 28,722 | -21.0% | 0.00% | 0.0% |
| Q1 2019 | $1,368,000 | -12.1% | 36,336 | -19.9% | 0.00% | 0.0% |
| Q4 2018 | $1,556,000 | -14.7% | 45,349 | +16.8% | 0.00% | 0.0% |
| Q3 2018 | $1,825,000 | +102.3% | 38,839 | +45.2% | 0.00% | – |
| Q2 2018 | $902,000 | +17940.0% | 26,740 | +13270.0% | 0.00% | – |
| Q1 2018 | $5,000 | -58.3% | 200 | -72.6% | 0.00% | – |
| Q4 2017 | $12,000 | -94.5% | 729 | -93.4% | 0.00% | – |
| Q3 2017 | $219,000 | +1464.3% | 10,972 | +1338.0% | 0.00% | – |
| Q2 2017 | $14,000 | -61.1% | 763 | -79.3% | 0.00% | – |
| Q1 2017 | $36,000 | +28.6% | 3,683 | +43.8% | 0.00% | – |
| Q4 2016 | $28,000 | -3.4% | 2,561 | +25.4% | 0.00% | – |
| Q3 2016 | $29,000 | -3.3% | 2,042 | -52.1% | 0.00% | – |
| Q2 2016 | $30,000 | -50.0% | 4,265 | -53.3% | 0.00% | – |
| Q1 2016 | $60,000 | -98.6% | 9,131 | -93.0% | 0.00% | -100.0% |
| Q4 2015 | $4,256,000 | +862.9% | 131,322 | +693.4% | 0.00% | – |
| Q3 2015 | $442,000 | -53.3% | 16,552 | -15.8% | 0.00% | -100.0% |
| Q2 2015 | $946,000 | -14.5% | 19,657 | +8.1% | 0.00% | 0.0% |
| Q1 2015 | $1,107,000 | -29.0% | 18,192 | -39.6% | 0.00% | 0.0% |
| Q4 2014 | $1,560,000 | -23.9% | 30,125 | -35.4% | 0.00% | 0.0% |
| Q3 2014 | $2,051,000 | +350.8% | 46,599 | +167.7% | 0.00% | – |
| Q2 2014 | $455,000 | +92.8% | 17,410 | +92.9% | 0.00% | – |
| Q1 2014 | $236,000 | -14.8% | 9,025 | -44.8% | 0.00% | – |
| Q4 2013 | $277,000 | +13.5% | 16,350 | +44.0% | 0.00% | – |
| Q3 2013 | $244,000 | – | 11,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |